Completed
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
NCT00289185
- Conditions
- Coccidiosis, Infections, Malaria, +6 more
- Locations
-
- GSK Investigational Site Dar es Salaam, Tanzania